We identified that the simultaneous targeting of CRL4-DCAF1 ubiquitin ligase activity and the Raf/MEK/ERK pathway had additive effects in inhibiting the proliferation and viability of Merlin-deficient meningioma cells. Here, IL17RB is linked to meningioma.